Feasibility, acceptability and clinical outcomes of a real-world, regional lung cancer prehabilitation programme for patients undergoing curative intent radiotherapy
Lung Cancer · 2025-06 · 204 · 108572
DOI: 10.1016/j.lungcan.2025.108572 ↗Kurz gefasst
Fachartikel in der Zeitschrift Lung Cancer, 2025-06. Verfasst von Ewan Gourlay und 7 weiteren Autor:innen. Beteiligte Einrichtung: Lung Cancer and Thoracic Surgery Directorate, Wythenshawe Hospital, Manchester University NHS Foundation Trust, Manchester, UK. Electronic address: e…. Hauptthemen laut MEDLINE: Lung Neoplasms. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 25 Literaturangaben.
Abstract (Originalsprache)
INTRODUCTION: Prehabilitation improves both physiological measurements and clinical outcomes for patients undergoing surgery for lung cancer. The feasibility, acceptability and efficacy of prehabilitation for patients having curative-intent radiotherapy for lung cancer is uncertain. METHODS: Prehab4Cancer (P4C) is a regional, community-based prehabilitation service for patients with cancer in Greater Manchester in the United Kingdom. We present an evaluation of the P4C service for patients undergoing curative-intent radiotherapy for lung cancer over a 2-year period. Feasibility was evaluated against prespecified key performance indicators. Objective physiological and subjective functional assessments were recorded before and after completion. Effects on mortality in comparison to a non-prehab cohort were assessed in an exploratory regression analysis. RESULTS: A total of 381 patients were referred to P4C via a web-based portal. 86 % (329/381) were contacted by phone and 73 % (279/381) completed an initial assessment. 45 % (172/381) completed the prehab programme with a median of 7 (IQR 3-11) sessions during a median time to commencing treatment of 23 days (IQR 16-34). Median time from referral to assessment was 4 days (IQR 3-6) and 86 % (239/279) were completed within 7 days of referral. Six-Minute Walk Tests improved by an average of 30 m (95 % CI 20.6-41 m, p =
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Lung Cancer and Thoracic Surgery Directorate, Wythenshawe Hospital, Manchester University NHS Foundation Trust, Manchester, UK. Electronic address: ewangourlay@nhs.net.
- The Christie NHS Foundation Trust, Manchester, UK.
- Lung Cancer and Thoracic Surgery Directorate, Wythenshawe Hospital, Manchester University NHS Foundation Trust, Manchester, UK.
- Respiratpry Department, North Manchester General Hospital, Manchester University NHS Foundation Trust, Manchester, UK.
- Prehab4cancer, Salford Council, Greater Manchester, UK.
- Lung Cancer and Thoracic Surgery Directorate, Wythenshawe Hospital, Manchester University NHS Foundation Trust, Manchester, UK; Manchester Academic Health Science Centre (MAHSC), Faculty of Biology, Medicine & Health, U…
Zitieren
APA
Gourlay, E., Banfill, K., Merchant, Z., Goodley, P., Brown, L., Murphy, J., Moore, J., & Evison, M. (2025). Feasibility, acceptability and clinical outcomes of a real-world, regional lung cancer prehabilitation programme for patients undergoing curative intent radiotherapy. Lung Cancer, 204, 108572. https://doi.org/10.1016/j.lungcan.2025.108572
Vancouver
Gourlay E, Banfill K, Merchant Z, Goodley P, Brown L, Murphy J, et al. Feasibility, acceptability and clinical outcomes of a real-world, regional lung cancer prehabilitation programme for patients undergoing curative intent radiotherapy. Lung Cancer. 2025;204:108572. doi:10.1016/j.lungcan.2025.108572
BibTeX
@article{Gourlay2025,
author = {Gourlay, Ewan and Banfill, Kathryn and Merchant, Zoe and Goodley, Patrick and Brown, Louise and Murphy, Jack and Moore, John and Evison, Matthew},
title = {Feasibility, acceptability and clinical outcomes of a real-world, regional lung cancer prehabilitation programme for patients undergoing curative intent radiotherapy},
journal = {Lung Cancer},
year = {2025},
volume = {204},
pages = {108572},
doi = {10.1016/j.lungcan.2025.108572}
}
EUVIMED